|4Nov 12, 8:00 PM ET

Chiang Kyle 4

4 · LogicBio Therapeutics, Inc. · Filed Nov 12, 2020

Insider Transaction Report

Form 4
Period: 2020-11-02
Chiang Kyle
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2020-11-02+85,00085,000 total
    Exercise: $5.65Exp: 2030-11-02Common Stock (85,000 underlying)
Footnotes (1)
  • [F1]25% vests on 11/02/2021 and the remainder vests in equal monthly installments over the next 36 months.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION